https://doi.org/10.4081/itjm.2021.1387

New-onset type 1 diabetes mellitus triggered by SARS-CoV-2 infection in a patient with Hashimoto thyroiditis: a case report

Vol. 15 No. 1 (2021)
Submitted: 9 October 2020
Accepted: 16 November 2020
Published: 25 January 2021
Diabetes, SARS-CoV-2, COVID-19, hyperglycemia, glutamic acid decarboxylase-65 autoantibodies.
Abstract Views: 802
PDF: 475
HTML: 28
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Elena Schipani
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Andrea Cozzi
https://orcid.org/0000-0002-9174-9601
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Giuseppe Salvatore Murgida
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Valentina Francolini
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Eleonora Sisti
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Stefania Di Martino
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Francesca Dainelli
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Rosa Vecchio
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Elisa Grifoni
https://orcid.org/0000-0002-7889-6367
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.
Luca Masotti
luca.masotti@tin.it
https://orcid.org/0000-0002-1208-9343
Internal Medicine II, San Giuseppe Hospital, Empoli (FI), Italy.

New-onset type 1 diabetes mellitus is an uncommon but possible complication triggered by severe acute respiratory syndrome-related coronavirus 2 infection. Metabolic inflammation supported by cytokine storm leading to pancreatic beta cells destruction is the most probable link between coronavirus disease 2019 (COVID-19) and diabetes. Here, we describe the case of a 51-year-old female suffering from Hashimoto thyroiditis, who came to our attention for new-onset polyuria-polydipsia syndrome associated with hyperglycemia after a mild form of COVID-19 recognized two months before and already recovered. Type 1 diabetes was diagnosed.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics  provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Baj J, Karakuła-Juchnowicz H, Teresiński G, et al. COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. J Clin Med 2020;9:1753.
Azar WS, Njeim R, Fares AH, et al. COVID-19 and diabetes mellitus: how one pandemic worsens the other [published online ahead of print, 2020 Aug 2]. Rev Endocr Metab Disord 2020;1-13.
Rubino F, Amiel SA, Zimmet P, et al. New-onset diabetes in Covid-19 [published online ahead of print, 2020 Jun 12]. N Engl J Med 2020;10.1056/NEJMc2018688.
Ruggeri RM, Campennì A, Siracusa M, et al. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic [published online ahead of print, 2020 Jul 16]. Hormones (Athens) 2020;1-3.
Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020;8:546-50.
Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect 2020;80:607-13.
Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic [published online ahead of print, 2020 Jul 9]. Rev Endocr Metab Disord 2020;1-13.
Bellastella G, Maiorino MI, Esposito K. Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?. J Endocrinol Invest 2020;43:1169-70.
Heaney AI, Griffin GD, Simon EL. Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection [published online ahead of print, 2020 Jun 6]. Am J Emerg Med 2020;S0735-6757(20)30488-5.
Marchand L, Pecquet M, Luyton C. Type 1 diabetes onset triggered by COVID-19 [published online ahead of print, 2020 Jul 11]. Acta Diabetol 2020;1-2.
Chee YJ, Ng SJH, Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract 2020;164:108166.

How to Cite

Schipani, E., Cozzi, A., Murgida, G. S., Francolini, V., Sisti, E., Di Martino, S. ., Dainelli, F., Vecchio, R., Grifoni, E., & Masotti, L. (2021). New-onset type 1 diabetes mellitus triggered by SARS-CoV-2 infection in a patient with Hashimoto thyroiditis: a case report. Italian Journal of Medicine, 15(1). https://doi.org/10.4081/itjm.2021.1387

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.